MBX-2982

MBX-2982

CAT N°: 22206
Price:

From 231.00 196.35

MBX-2982 is an agonist of GPR119.{36741} It reduces nuclear and total protein levels of sterol regulatory element binding protein 1 (SREBP-1) in HepG2 cells and rat primary hepatocytes under high-glucose and -insulin conditions and increases phosphorylation of the inhibitory form, SREBP-1c. MBX-2982 (10 mg/kg) inhibits hepatic lipid accumulation in wild-type, but not GPR119 knockout, mice fed a high-fat diet. It also increases plasma levels of glucagon-like peptide 1 (GLP-1; Item No. 24460) in mice when administered at a dose of 10 mg/kg prior to, and to a greater extent following, glucose administration.{36742} MBX-2982 increases glucokinase activity in an enzyme assay with an EC50 value of 45.11 µM.{36743}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • 5-ethyl-2-[4-[4-[[4-(1H-tetrazol-1-yl)phenoxy]methyl]-2-thiazolyl]-1-piperidinyl]-pyrimidine
  • Correlated keywords
    • MBX2982 GPR-119 SREBP1 SREBP1c HepG- Hep-G2 GLP1
  • Product Overview:
    MBX-2982 is an agonist of GPR119.{36741} It reduces nuclear and total protein levels of sterol regulatory element binding protein 1 (SREBP-1) in HepG2 cells and rat primary hepatocytes under high-glucose and -insulin conditions and increases phosphorylation of the inhibitory form, SREBP-1c. MBX-2982 (10 mg/kg) inhibits hepatic lipid accumulation in wild-type, but not GPR119 knockout, mice fed a high-fat diet. It also increases plasma levels of glucagon-like peptide 1 (GLP-1; Item No. 24460) in mice when administered at a dose of 10 mg/kg prior to, and to a greater extent following, glucose administration.{36742} MBX-2982 increases glucokinase activity in an enzyme assay with an EC50 value of 45.11 µM.{36743}

We also advise you